文献速递产科

阿片类未暴露患者与阿片类使用障碍患者产后阿片类药物消耗量及出院阿片类处方比较

A comparison of postpartum opioid consumption and opioid discharge prescriptions among opioid-naïve patients and those with opioid use disorder.
PubMed 文献 · Am J Obstet Gynecol MFM · 2023-05-19

这项回顾性队列研究纳入2014年5月至2020年4月单家三级学术医院分娩的16140例妊娠,比较阿片类使用障碍患者与阿片类未暴露患者的产后阿片消耗及出院处方。阿片类使用障碍患者(n=553)每日消耗量较未暴露者(n=15587)多14毫克吗啡当量(95%CI 11-17),剖宫产者多30毫克吗啡当量(95%CI 26-35),但剖宫产阿片类使用障碍患者出院阿片处方比例更低(68% vs 77%,P=.002)。

要点

  • 阿片类使用障碍患者产后每日阿片消耗较未暴露者多14毫克吗啡当量(95%CI 11-17)。
  • 剖宫产阿片类使用障碍患者每日消耗较未暴露者多30毫克吗啡当量(95%CI 26-35)。
  • 剖宫产阿片类使用障碍患者出院阿片处方比例低于未暴露者(68% vs 77%,P=.002)。

核心结论

  • 阿片类使用障碍患者无论接受美沙酮、丁丙诺啡还是未用药治疗,剖宫产后阿片消耗量均显著高于阿片类未暴露者,但出院时获得的阿片处方更少。

研究设计与样本

  • 回顾性队列研究,纳入2014年5月至2020年4月单家三级学术医院分娩的16140例妊娠,其中阿片类使用障碍553例,阿片类未暴露15587例。

主要发现

  • 阿片类使用障碍患者(n=553)产后每日阿片消耗量较阿片类未暴露者(n=15587)多14毫克吗啡当量(95%CI 11-17)。
  • 剖宫产阿片类使用障碍患者每日阿片消耗量较阿片类未暴露者多30毫克吗啡当量(95%CI 26-35)。
  • 阴道分娩患者中,阿片类使用障碍与未暴露者的阿片消耗量无差异。
  • 与美沙酮治疗者相比,丁丙诺啡治疗者和未用药治疗者在阴道分娩及剖宫产后阿片消耗量相似。
  • 剖宫产患者中,阿片类未暴露者出院获得阿片处方的比例高于阿片类使用障碍患者(77% vs 68%;P=.002),尽管前者疼痛评分更低且住院期间阿片消耗更少。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Management of patients with opioid use disorder during the acute postpartum period remains clinically challenging as obstetricians aim to mitigate postdelivery pain while optimizing recovery support. OBJECTIVE: This study aimed to evaluate postpartum opioid consumption and opioids prescribed at discharge among patients with opioid use disorder treated with methadone, buprenorphine, and no medication for opioid use disorder, as compared with opioid-naïve counterparts. STUDY DESIGN: We conducted a retrospective cohort study of pregnant patients who underwent delivery at >20 weeks' gestation at a tertiary academic hospital between May 2014 and April 2020. The primary outcome of this analysis was the mean daily quantity of oral opioids consumed after delivery while inpatient, in milligrams of morphine equivalents. Secondary outcomes included the following: (1) quantity of oral opioids prescribed at discharge, and (2) prescription for oral opioids in the 6 weeks after hospital discharge. Multiple linear regression was used to compare differences in the primary outcome. RESULTS: A total of 16,140 pregnancies were included. Patients with opioid use disorder (n=553) consumed 14 milligrams of morphine equivalents per day greater quantities of opioids postpartum than opioid-naïve women (n=15,587), (95% confidence interval, 11-17). Patients with opioid use disorder undergoing cesarean delivery consumed 30 milligrams of morphine equivalents per day greater quantities of opioids than opioid-naïve counterparts (95% confidence interval, 26-35). Among patients who underwent vaginal delivery, there was no difference in opioid consumption among patients with and without opioid use disorder. Compared with patients prescribed methadone, patients prescribed buprenorphine, and those prescribed no medication for opioid use disorder consumed similar opioid quantities postpartum following both vaginal and cesarean delivery. Among patients undergoing cesarean delivery, opioid-naïve patients were more likely to receive a discharge prescription for opioids than patients with opioid use disorder (77% vs 68%; P=.002), despite lower pain scores and less inhospital opioid consumption. CONCLUSION: Patients with opioid use disorder, regardless of treatment with methadone, buprenorphine, or no medication for opioid use disorder consumed significantly greater quantities of opioids after cesarean delivery but received fewer opioid prescriptions at discharge.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Holland E, Gibbs L, Spence NZ, et al. A comparison of postpartum opioid consumption and opioid discharge prescriptions among opioid-naïve patients and those with opioid use disorder. Am J Obstet Gynecol MFM. 2023. PMID: 37211090. doi:10.1016/j.ajogmf.2023.101025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。